Elkfork Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	$21K	Hold	264	–	–	﹤0.01%	1029
2019 Q2	$25K	Buy	264 +110	+71%	+$10.4K	﹤0.01%	1025
2019 Q1	$13K	Sell	154 -44	-22%	-$3.71K	﹤0.01%	1027
2018 Q4	$11K	Buy	+198	New	+$11K	﹤0.01%	1005